FR1437M - New sulfonamide, usable in therapy, in particular as a central stimulant and analeptic. - Google Patents

New sulfonamide, usable in therapy, in particular as a central stimulant and analeptic.

Info

Publication number
FR1437M
FR1437M FR868784A FR868784A FR1437M FR 1437 M FR1437 M FR 1437M FR 868784 A FR868784 A FR 868784A FR 868784 A FR868784 A FR 868784A FR 1437 M FR1437 M FR 1437M
Authority
FR
France
Prior art keywords
analeptic
usable
therapy
central stimulant
new sulfonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR868784A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH599660A external-priority patent/CH405286A/en
Priority claimed from FR862619A external-priority patent/FR1310509A/en
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Priority to FR868784A priority Critical patent/FR1437M/en
Application granted granted Critical
Publication of FR1437M publication Critical patent/FR1437M/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR868784A 1960-05-25 1961-07-24 New sulfonamide, usable in therapy, in particular as a central stimulant and analeptic. Expired FR1437M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR868784A FR1437M (en) 1960-05-25 1961-07-24 New sulfonamide, usable in therapy, in particular as a central stimulant and analeptic.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH599660A CH405286A (en) 1960-05-25 1960-05-25 Process for the production of new sulfonamides
CH498361 1961-04-28
FR862619A FR1310509A (en) 1961-05-24 1961-05-24 Process for the preparation of novel sulfonamides, in particular of 1, 4-endoalkylene-cyclohexane-2-sulfonamides
FR868784A FR1437M (en) 1960-05-25 1961-07-24 New sulfonamide, usable in therapy, in particular as a central stimulant and analeptic.

Publications (1)

Publication Number Publication Date
FR1437M true FR1437M (en) 1962-08-13

Family

ID=87798496

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868784A Expired FR1437M (en) 1960-05-25 1961-07-24 New sulfonamide, usable in therapy, in particular as a central stimulant and analeptic.

Country Status (1)

Country Link
FR (1) FR1437M (en)

Similar Documents

Publication Publication Date Title
FR1761M (en) New pyridine, usable in therapy, in particular as an antimycotic and disinfectant.
CH385086A (en) Building block, in particular toy building block
FR308M (en) New pyridyl-ethyl-guanidine usable in therapy.
FR302M (en) New m-butoxy-phenoxy-ethylamine usable in therapy.
FR1437M (en) New sulfonamide, usable in therapy, in particular as a central stimulant and analeptic.
BE608883A (en) Advanced battery.
FR1545M (en) 11-oxygen-progesterone-3,20-dioximes.
FR147M (en) N, n-dimethyl-2-phenyl-2-benzoyloxymethylbutylamine and its addition salts.
FR1898M (en) New substance usable in therapy.
FR2407M (en) New basic ketone usable in therapy, in particular as a stimulant.
FR349M (en) New 1,3-dihydroxy-2-nitro-tricos-4-yne usable in therapy.
FR1029M (en) New 17α-isobutyl-androstane-3β, 17β-diol usable in therapy.
FR307M (en) New guanidine usable in therapy.
BE596272A (en) New substance usable in therapy.
FR1494M (en) New creation in therapy.
FR115M (en) New sulfonamide usable in therapy.
FR222M (en) New 2,5-bis-ethylene-imino-3,6-bis-acylamino-p-benzoquinone usable in therapy.
FR353M (en) New quinoline usable in therapy.
FR309M (en) New piperazino-ethyl-guanidine usable in therapy.
FR67733E (en) Pumps, in particular positive displacement pumps
FR350M (en) New antibiotic lankavamycin usable in therapy.
FR303M (en) New guanidine usable in therapy.
FR2745M (en) New sulfonamide which can be used in therapy, in particular as a chemotherapeutic agent.
FR3248M (en) New sulfonamide which can be used in therapy, in particular as a chemotherapeutic agent.
FR2714M (en) New sulfonamide which can be used in therapy, in particular as a chemotherapeutic agent.